Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Return on Assets (2016 - 2025)

Rocket Pharmaceuticals' Return on Assets history spans 10 years, with the latest figure at 0.66% for Q4 2025.

  • For Q4 2025, Return on Assets fell 8.0% year-over-year to 0.66%; the TTM value through Dec 2025 reached 0.66%, down 8.0%, while the annual FY2025 figure was 0.54%, 5.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.66% at Rocket Pharmaceuticals, down from 0.63% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.26% in Q1 2021 and bottomed at 0.66% in Q4 2025.
  • The 5-year median for Return on Assets is 0.48% (2022), against an average of 0.48%.
  • The largest annual shift saw Return on Assets increased 2bps in 2023 before it dropped -15bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.33% in 2021, then plummeted by -41bps to 0.46% in 2022, then increased by 4bps to 0.44% in 2023, then plummeted by -32bps to 0.58% in 2024, then decreased by -14bps to 0.66% in 2025.
  • Per Business Quant, the three most recent readings for RCKT's Return on Assets are 0.66% (Q4 2025), 0.63% (Q3 2025), and 0.59% (Q2 2025).